LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

The QiaSymphony DSP DNA Midi kit (Photo courtesy of Qiagen)

Genomes of Advanced Neuroendocrine Neoplasms Unveil Subtypes

Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and genetically heterogeneous malignancies, characterized by distinct prognoses based upon primary tumor localization, functionality, grade, proliferation index and diverse outcomes to treatment. More...
13 Aug 2021
Bone marrow aspirate from a patient with Precursor T-cell Acute Lymphoblastic Leukemia (Photo courtesy of Dr. Peter Maslak, MD)

Early T-Cell Precursor Lymphoblastic Lymphoma Characterized

T-cell lymphoblastic lymphoma (T-LLy) is an aggressive neoplasm of immature T-cell precursors and represents 25% to 30% of childhood non-Hodgkin lymphoma. More...
13 Aug 2021
The MiSeqDx System is the first FDA-regulated, CE-IVD-marked, NGS platform for in vitro diagnostic (IVD) testing (Photo courtesy of Illumina)

Insulin Resistance and T2D Associated With Gut Microbial Diversity

Type 2 diabetes (T2D) is a common complex metabolic disorder. Currently, more than 380 million people live with type 2 diabetes globally, and this number is expected to increase to more than 550 million by 2030. More...
13 Aug 2021
The SuperScript III Reverse Transcriptase (RT) kit provides increased specificity with gene-specific primers (GSPs) and the highest cDNA yield of all RTs (Photo courtesy of Thermo Fisher Scientific).

Molecular Assays Compared For MRD Detection In B-ALL

B-cell precursor acute lymphoblastic leukemia (B-ALL) is the most common malignancy in children, and it may be associated with gene alterations that regulate B-cell development. The prognostic significance of minimal residual disease (MRD) in children with acute lymphoblastic leukemia (ALL) has been demonstrated. More...
11 Aug 2021
Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease (Photo courtesy of Massachusetts General Hospital)

Microbiome and Metabolic Features Tied to IBD Treatment Response

Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's disease and ulcerative colitis are the principal types of inflammatory bowel disease. More...
06 Aug 2021
Real-world data support the clinical utility of the Decipher Prostate Biopsy Genomic Test for determining prostate cancer treatment options (Photo courtesy of Clinical Lab Products)

Genomic Test Aids in Determining Prostate Cancer Treatment Options

A clinical study has confirmed that a commercially available genomic test was useful for identifying which prostate cancer patients would benefit from more immediate and aggressive treatment. More...
06 Aug 2021
Typical RNA sequencing workflow (Photo courtesy of Wikimedia Commons)

Advanced Sequencing Techniques Determine Cancer Genome Variants in Young Patients

A recent paper described a three-platform sequencing approach, including whole genome (WGS), exome, and RNA sequencing, that was used to examine tumor and germline genomes from prospectively identified children with newly diagnosed or relapsed/refractory cancers. More...
03 Aug 2021
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Steam Sterilizer
Hi Vac II Line
New
Electrolyte Analyzer
BKE-B


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
ADLM